Elizabeth A. Garofalo serves as Executive at ACADIA PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Elizabeth A. Garofalo has executed 14 insider transactions totaling $137.2K, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 2, 2025 involved selling 1,600 shares valued at $41.6K.
Elizabeth A. Garofalo currently holds 25,382 shares of ACADIA PHARMACEUTICALS INC (ACAD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Elizabeth A. Garofalo has been a net seller of ACAD stock. They have purchased $0 and sold $137.2K worth of shares.
Elizabeth A. Garofalo's most recent insider trade was on Sep 2, 2025, when they sold 1,600 shares at $25.98 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| May 29, 2024 | ACAD | $0 | Option Exercise | 6,652 | $N/A | Discretionary |
| Mar 8, 2024 | XENE | $65.0K | Payment | 1,408 | $46.16 | Discretionary |
| Mar 8, 2024 | XENE | $95.6K | Sale | 2,092 | $45.69 | Discretionary |
| Mar 8, 2024 | XENE | $65.0K | Option Exercise | 3,500 | $18.56 | Discretionary |
| Dec 5, 2023 | ALEC | $0 | Gift | 9,459 | $N/A | Discretionary |
| Nov 24, 2023 | ACAD | $0 | Gift | 2,918 | $N/A | Discretionary |
| Jun 14, 2023 | ALEC | $0 | Award | 26,250 | $N/A | Discretionary |
| Jun 1, 2023 | ACAD | $0 | Option Exercise | 8,552 | $N/A | Discretionary |
| Sep 29, 2022 | ACAD | $0 | Option Exercise | 1,919 | $N/A | Discretionary |
| Jun 16, 2022 | ALEC | $0 | Award | 9,459 | $N/A | Discretionary |
| Jun 7, 2022 | ACAD | $0 | Option Exercise | 6,391 | $N/A | Discretionary |
| Sep 29, 2021 | ACAD | $0 | Option Exercise | 1,918 | $N/A | Discretionary |